Stephanie Grünewald

7.1k total citations · 1 hit paper
85 papers, 2.1k citations indexed

About

Stephanie Grünewald is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Stephanie Grünewald has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 28 papers in Clinical Biochemistry and 27 papers in Physiology. Recurrent topics in Stephanie Grünewald's work include Glycosylation and Glycoproteins Research (29 papers), Metabolism and Genetic Disorders (28 papers) and Lysosomal Storage Disorders Research (15 papers). Stephanie Grünewald is often cited by papers focused on Glycosylation and Glycoproteins Research (29 papers), Metabolism and Genetic Disorders (28 papers) and Lysosomal Storage Disorders Research (15 papers). Stephanie Grünewald collaborates with scholars based in United Kingdom, United States and Belgium. Stephanie Grünewald's co-authors include Gert Matthijs, Els Schollen, Ron A. Wevers, Éva Morava, Peter T. Clayton, Suzan Wopereis, Karin Huijben, James V. Leonard, Alexander Broomfield and Aleksandra Jezela‐Stanek and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Stephanie Grünewald

84 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia

2024 55 citations Dwight D. Koeberl, Andreas Schulze et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephanie Grünewald United Kingdom	28	1.4k	558	516	354	338	85	2.1k
Celia Pérez‐Cerdá Spain	30	1.8k 1.3×	1.3k 2.4×	412 0.8×	325 0.9×	156 0.5×	119	2.5k
Christian Thiel Germany	25	1.3k 0.9×	180 0.3×	413 0.8×	336 0.9×	403 1.2×	66	1.8k
Filippo Pinto e Vairo Brazil	20	569 0.4×	235 0.4×	602 1.2×	226 0.6×	88 0.3×	111	1.4k
Yanling Yang China	19	857 0.6×	505 0.9×	117 0.2×	209 0.6×	46 0.1×	138	1.5k
Terttu Suormala Switzerland	30	1.5k 1.1×	1.3k 2.3×	207 0.4×	203 0.6×	395 1.2×	81	2.7k
Natalia I. Krupenko United States	25	1.1k 0.8×	191 0.3×	115 0.2×	79 0.2×	68 0.2×	54	1.6k
Jane M. Quirk United States	23	784 0.5×	95 0.2×	2.0k 3.9×	202 0.6×	618 1.8×	31	2.5k
Manisha Balwani United States	28	1.6k 1.1×	101 0.2×	1.1k 2.2×	87 0.2×	332 1.0×	114	2.6k
Kazuko Sukegawa Japan	30	627 0.4×	106 0.2×	1.8k 3.6×	177 0.5×	618 1.8×	100	2.3k
Amparo Chabás Spain	26	727 0.5×	65 0.1×	1.4k 2.7×	106 0.3×	503 1.5×	90	1.8k

Countries citing papers authored by Stephanie Grünewald

Since Specialization

Citations

This map shows the geographic impact of Stephanie Grünewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Grünewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Grünewald more than expected).

Fields of papers citing papers by Stephanie Grünewald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Grünewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Grünewald. The network helps show where Stephanie Grünewald may publish in the future.

Co-authorship network of co-authors of Stephanie Grünewald

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Grünewald. A scholar is included among the top collaborators of Stephanie Grünewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Grünewald. Stephanie Grünewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baruteau, Julien, Anil Dhawan, Anupam Chakrapani, et al.. (2025). P008: A first in human, single arm, open label phase 1/2 study evaluating ECUR-506 in neonatal OTC Deficiency: Initial Observations. Genetics in Medicine Open. 3. 102852–102852. 1 indexed citations

Koeberl, Dwight D., Andreas Schulze, Neal Sondheimer, et al.. (2024). Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature. 628(8009). 872–877. 55 indexed citations breakdown →

Cerisuelo, Miriam Cortés, Wayel Jassem, Hector Vilca‐Melendez, et al.. (2023). Transplantation in paediatric patients with MMA requires multidisciplinary approach for achievement of good clinical outcomes. Pediatric Nephrology. 38(8). 2887–2896. 4 indexed citations

Hartley, Louise, et al.. (2023). Prolonged respiratory failure responds to conventional therapy in isolated homocysteine remethylation defects. JIMD Reports. 64(4). 274–281. 1 indexed citations

Forny, Patrick, Emma Footitt, James Davison, et al.. (2021). Diagnosing Mitochondrial Disorders Remains Challenging in the Omics Era. Neurology Genetics. 7(3). e597–e597. 16 indexed citations

Magrinelli, Francesca, Eoin Mulroy, Susanne A. Schneider, et al.. (2020). Criss-cross gait. Neurology. 95(11). 500–501. 7 indexed citations

Conte, Federica, Éva Morava, Nurulamin Abu Bakar, et al.. (2020). Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots. Molecular Genetics and Metabolism. 131(1-2). 135–146. 19 indexed citations

Baruteau, Julien, Stephanie Grünewald, Marta Zancolli, et al.. (2019). Urea Cycle Related Amino Acids Measured in Dried Bloodspots Enable Long-Term In Vivo Monitoring and Therapeutic Adjustment. Metabolites. 9(11). 275–275. 3 indexed citations

Vockley, Jerry, Barbara K. Burton, Gerard T. Berry, et al.. (2017). UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24 weeks of treatment. Molecular Genetics and Metabolism. 120(4). 370–377. 58 indexed citations

10.

Stabej, Polona Le Quesne, Chela James, Louise Ocaka, et al.. (2017). An example of the utility of genomic analysis for fast and accurate clinical diagnosis of complex rare phenotypes. Orphanet Journal of Rare Diseases. 12(1). 24–24. 14 indexed citations

11.

Taylor, Rachel L., Gavin Arno, James A. Poulter, et al.. (2017). Association of Steroid 5α-Reductase Type 3 Congenital Disorder of Glycosylation With Early-Onset Retinal Dystrophy. JAMA Ophthalmology. 135(4). 339–339. 32 indexed citations

12.

Reid, Emma, Apostolos Papandreou, Suzanne Drury, et al.. (2016). Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. Brain. 139(11). 2844–2854. 27 indexed citations

13.

Cleary, Maureen, et al.. (2016). Swallow Prognosis and Follow-Up Protocol in Infantile Onset Pompe Disease. JIMD Reports. 33. 11–17. 10 indexed citations

14.

Heywood, Wendy, Philippa B. Mills, Jale Yüzügülen, et al.. (2016). Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation. Molecular Genetics and Metabolism Reports. 7. 55–62. 9 indexed citations

15.

Grünewald, Stephanie. (2009). The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(9). 827–834. 90 indexed citations

16.

Grünewald, Stephanie. (2007). Congenital disorders of glycosylation: Rapidly enlarging group of (neuro)metabolic disorders. Early Human Development. 83(12). 825–830. 29 indexed citations

17.

Keldermans, Liesbeth, An Snellinx, Jean‐François Collet, et al.. (2005). Tissue distribution of the murine phosphomannomutases Pmm1 and Pmm2 during brain development. European Journal of Neuroscience. 22(4). 991–996. 10 indexed citations

18.

Grünewald, Stephanie. (2002). Congenital Disorders of Glycosylation: A Review. Pediatric Research. 52(5). 618–624. 27 indexed citations

19.

Leonard, James V., Stephanie Grünewald, & Peter T. Clayton. (2001). Diversity of congenital disorders of glycosylation. The Lancet. 357(9266). 1382–1383. 17 indexed citations

20.

Matthijs, Gert, et al.. (2000). Partial deficiency of phosphomannomutase: a pitfall in the diagnosis of congenital disorders of glycosylation (CDG-Ia). The American Journal of Human Genetics. 67(4). 36–36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact